Results 111 to 120 of about 57,488 (212)
抗病毒治疗对不同分期的乙型肝炎相关慢加急性 肝衰竭患者短期生存率的影响
Zhongshan Daxue xuebao. Yixue kexue ban, 2010 【目的】 探讨抗病毒治疗对不同分期的乙型肝炎相关慢加急性肝衰竭患者转归的影响65377;【方法】 352例乙型肝炎相关慢加急性肝衰竭患者,其中早期患者120例65380;中期患者149例65380;晚期患者83例,各期患者分为常规治疗组及抗病毒治疗组,抗病毒治疗组在常规内科治疗基础上加用抗病毒药物治疗(拉米夫定65380;恩替卡韦65380;替比夫定),比较各期患者临床特征65380;生存率及抗病毒治疗短期疗效差异65377;【结果】 观察24周,乙型肝炎相关慢加急性肝衰竭早65380;中65380 ...
doaj
[Exploring the Causal Relationship Between Circulating Immune Cells and Autoimmune Hepatitis Through Mendelian Randomization Analysis]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue BanLeng S, Wang K, Shi Y, Deng C.
europepmc +1 more source
[Progress in the research of HBV reactivation in patients undergoing hematopoietic stem cell transplantation]. [PDF]
Zhonghua Xue Ye Xue Za Zhi, 2021 Niu JX, Xu Y, Wu DP.
europepmc +1 more source
[Altered oral microbiome and metabolites are associated with improved lipid metabolism in HBV-infected patients with metabolic dysfunction-associated fatty liver disease]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoZhang J +9 more
europepmc +1 more source
Zhongshan Daxue xuebao. Yixue kexue ban, 1989 对广州地区49例散发性急性非甲非乙型肝炎(HNANB)病人进行临床和流行病学研究认为:①乙型肝炎与HNANB的二重感染并不少见;②本组散发性HNANB病例与输血、注射等途径无关,在临床和流行病学上与甲肝相似,可能属于经胃肠道传播的HNANB ...
doaj